Autism is a pervasive developmental disorder affecting more males than females. Heritability estimates for autism can rise above 90%, and genes influencing the serotonin system are strong candidates for autism susceptibility genes, as drugs selectively acting on the serotonin system are some of the most effective treatments for maladaptive behaviors seen in autism. ITGB3 was recently identified as a male quantitative trait locus (QTL) for whole-blood serotonin levels in the Hutterites (P ¼ 0.0003). Here, we demonstrate associations between variation in ITGB3 and serotonin levels in two outbred samples (P ¼ 0.010 and 0.015). Lastly, we show that a coding variant of ITGB3 is associated with autism susceptibility in a large multiplex sample (P ¼ 0.00082), and that this variation has different effects in males and females (P ¼ 0.0018).
Introduction
Autism is a pervasive developmental disorder that impairs reciprocal social interaction and communication, and is associated with restricted and repetitive behaviors. 1 Narrowly defined 'autistic disorder' has an estimated prevalence of approximately one in 500 children, although as many as one in 166 children may present on the broader autism spectrum. 2, 3 Approximately 80% of individuals with autism are male. Although idiopathic autism is strongly genetic, no common susceptibility alleles have been conclusively implicated, and the underlying biology is poorly understood. 4 One of the oldest and most replicated findings is hyperserotonemia, or elevated platelet serotonin levels, in about 30% of individuals with autism. 5, 6 Moreover, subjects with autism who have an affected sibling show higher levels of platelet serotonin compared with subjects without an affected sibling. 7 Several studies have revealed positive correlation of serotonin levels between affected individuals and their first-degree (unaffected) relatives (0.50oro0.71), further suggesting the heritability of this trait. 8, 9 In addition, selective serotonin reuptake inhibitors (SSRIs) and atypical antipsychotic medications, which are often effective in autism to treat disruptive anxiety-related behaviors and aggression, respectively, act on the serotonin system. 10, 11 Data thus suggest that at least some of the serotonin dysregulation in autism families is not secondary to autism, but rather may inform us about a heritable predisposing factor. Functional variants at the serotonin transporter locus (SLC6A4) have been associated with autism in some studies, 12, 13 but these polymorphisms do not account for all of the variation in serotonin levels among the autism population. 14 -17 Recently, the b3-integrin gene (ITGB3)
was identified as a quantitative trait locus (QTL) for wholeblood serotonin levels, primarily in male subjects as compared with female subjects. 18, 19 This finding implicates a locus with no previously recognized role in serotonin regulation. We hypothesized that more detailed analysis of ITGB3 might reveal functional variation, clarify the mechanism underlying its association with serotonin levels, and explain the sex-specific effects in association.
We previously showed that variation in ITGB3 is associated with endophenotypes for common diseases, such as cardiovascular disease 20 and asthma, 21 whose etiologies may be influenced by serotonin physiology. However, serotonin is best known for its role as a neurotransmitter important in central nervous system function and psychiatric disease. Thus, an important aim of our study was to test for association between ITGB3 and autism. The ITGB3 gene has 15 exons and spans 60 kb on chromosome 17q21.3, about 20 cM distal to SLC6A4. The encoded b3 integrin is a subunit of the platelet-and megakaryocyte-specific heterodimeric fibrinogen receptor and the widely expressed heterodimeric vitronectin receptor. In addition to roles in platelet activation and adhesiondependent tissue modeling, integrin receptors have been shown to have signaling roles that can influence transcription and translation. 22 -24 The ITGB3 Leu33Pro singlenucleotide polymorphism (SNP), encoding the platelet antigen Pl A1/A2 (or HPA-1a/1b), is associated with functional properties of fibrinogen receptors, such as differential platelet adhesion and aggregation. 25 -27 This SNP was identified as a QTL for whole-blood serotonin level in a genome-wide association study in the Hutterites, a young founder population of European descent. 19 However, variation in the gene other than Leu33Pro had not been comprehensively evaluated in this or other populations. Thus, the aims of this study were to (1) fine map the association between serotonin level and ITGB3 in the Hutterites, (2) evaluate associations between ITGB3 alleles and serotonin levels in outbred populations, and (3) test for association between variation in ITGB3 and autism.
Materials and methods

Hutterites
Details of the Hutterite founder population, sampling strategy, and the utility of this population for mapping complex traits have been described previously. 19, 28, 29 Briefly, whole-blood serotonin was measured in 567 Hutterites (300 female and 267 male subjects), who are related in a 1623-person pedigree, 28 after obtaining informed consent. 19, 29 The distribution of the serotonin levels (191779 ng/ml; male subjects: 174776 ng/ml; female subjects: 206779 ng/ml) was normalized by lntransformation in order to use statistical tools relying on a normal distribution. These studies were approved by The University of Chicago and University of South Dakota Institutional Review Boards.
Chicago controls
We measured whole-blood serotonin level in healthy outbred adults (418 years) who were ascertained as controls for genetic studies of asthma. The control subjects reported either three or four grandparents of European ancestry (N ¼ 206) or of African or African-American ancestry (N ¼ 186). Serotonin levels were measured, using methods described for the Hutterite samples, 19 in a subset of the controls corresponding to 56 European Americans (14 male subjects: 179767 ng/ml; 42 female subjects: 172774 ng/ml) and 36 African Americans (11 male subjects: 220793 ng/ml; 25 female subjects: 200787 ng/ml).
Chicago autism sample
The Chicago autism sample consisted of 87 outbred Caucasian trios (affected child and parents). Recruitment, assessment, and inclusion criteria were the same as those outlined by Kim et al, 30 but only one sibling was randomly selected from each affected sibling pair, and subjects (1) had sufficient blood or DNA available for fine mapping studies and (2) met Autism Diagnostic Interview-Revised (ADI-R 31 ) and Autism Diagnostic Observation Schedule (ADOS-G 32 ) criteria for classification of autistic disorder.
The samples from which serotonin was measured (and not reported previously) corresponded to 50 Caucasian autism probands (age ¼ 5.973.3 years) from The University of Chicago who were not taking psychotropic medications (39 male and 11 female subjects). Whole-blood serotonin was measured by high-performance liquid chromatography (using methods described for the Hutterites 19 ), and the distribution of levels was 244781 ng/ml for male subjects, 222764 ng/ml for female subjects, and 239777 ng/ml overall. 
Vanderbilt autism sample
Sequencing
In order to identify common variation in the exons and splice junctions of ITGB3, we selected 12 Hutterite subjects representing all ITGB3 haplotypes 41%, defined by the 15 SNPs previously genotyped in this population. 20 Primers were designed based on the reference sequence (hg16) to amplify all exons and 445 bp of flanking sequence, 1400 bp of the region 5 0 to exon 1, and one region each in introns 2 and 13 identified as conserved noncoding sequences by the Comparative Genomic Resources for Cardiovascular Research using VISTA. Primer sequences and sequencing protocols are available upon request. Sequencing reactions were performed with BigDye v.3.1 (Applied Biosystems, Foster City, CA, USA) and resolved on an ABI 3100. Denaturing high-performance liquid chromatography was used to rule out sequence variation in eight instances (o3% amplicons) when sequencing reactions repeatedly failed. DNA sequence was assembled and analyzed using PolyPhred. Table 2 ). Intermarker linkage disequilibrium (LD) was measured using the r 2 statistic, as implemented on the Innate Immunity Programs for Genomics Applications website. SNPs were chosen and genotyped in the autism family samples based in part on results from Hutterite and outbred control studies (SNPs 1, 4, 8, and 11), and in part based on Caucasian HapMap data as tags for common (X5%) haplotypes across the transcriptional unit (SNPs 1, 16, and 20 -23). All genotyping was performed blinded to sample identity and affection status. Genotyping methods for each SNP are shown in Supplementary Table 3 .
Statistical analysis
All genotype data were assessed for Hardy -Weinberg equilibrium. An association test for quantitative phenotypes that takes into account relationships among individuals was used to analyze Hutterite data. In this test, the effect of an allele was represented as a main effect in a linear model, as described previously. 18, 34 The multipoint allele-specific homozygosity by descent test relies on the existence of regions that are homozygous by descent in inbred individuals to detect QTLs that act in a recessive manner. Age and sex were included as covariates in these analyses (see Ober et al 29 for details) and significance was assessed using a permutation test. 34 To estimate effect size of associated alleles in the Hutterites, we performed a generalized linear regression of the transformed phenotype values on the covariates, using the estimated covariance matrix (obtained as described by Abney et al 34 ) as weights in the Hutterite analysis. We performed this twice for each allele we tested, once under the null hypothesis, with only age and sex as covariates, and once under the alternative hypothesis, with genotype data included as an additional covariate. To estimate the percent variance explained by an allele, we calculated the residual sum of squares (RSS) for each regression and used the equation (RSS null ÀRSS alt )/RSS null . Association tests of serotonin levels in the control and autism samples were performed by linear regression using an additive model at each SNP. Age and sex were used as covariates in the analysis of autism subjects. Age was used as a covariate in the outbred controls, but sex and race were not significant covariates in this sample (P40.1). In addition, by looking at the distribution of serotonin level by genotype in each group, we determined that allelic relationships with serotonin did not differ between Caucasians and African Americans at each SNP; we therefore combined the overall sample for analysis. The transmission disequilibrium test (TDT), as implemented by Genehunter, 35 was performed to test for joint linkage and association in the Chicago autism trios. A family-based association test, as implemented in FBAT, 36 was performed to test for association in the Vanderbilt autism sample, initially under an additive model and subsequently under a dominant model. Because part of this sample overlapped with samples showing linkage in the region, we also reanalyzed association using FBAT taking linkage into account. 37 Sex differences were assessed using the program MODEL as implemented in an analysis module of the Genetic Power Calculator. It uses a log-linear approach to fit genetic models to multiple TDT samples and test for equal effects across samples (female affected vs male affected, in this case). 38 
Results
Resequencing ITGB3 reveals no additional coding variation By sequencing individuals representing all common haplotypes in the Hutterites (frequency 41%) for ITGB3 exons, flanking sequence, and conserved regions, we identified 17 SNPs, including two that were previously undocumented (rs17225109 and rs17218711). Four of the 17 SNPs were not among those we had previously genotyped in the Hutterites 20 and identified new haplotypes; these were genotyped in the Hutterite sample (SNPs 9, 14, 16, and 17; Figure 1a) . None of the variation we observed, except the previously genotyped Leu33Pro, 19 changed the coding sequence or splice donor/acceptor sites in ITGB3. Of the remaining 16 SNPs, four were silent SNPs in exons, three were in the 5 0 region, six were intronic, and three were in the 3 0 -untranslated region (Figure 1a ).
Noncoding SNPs in ITGB3 are associated with serotonin level in the Hutterites, controls, and autism patients Although many of the ITGB3 SNPs show strong associations to serotonin level in the Hutterites (Figure 1b) , we previously reported that none of the SNPs that were genotyped in the flanking genes, MYL4 or FLJ40342, are associated. 20 This is consistent with strong LD between a number of SNPs across ITGB3 in the Hutterites (eg SNPs 5 and 13), but negligible LD between genes (Figure 2 ). Because the linkage and association signals at ITGB3 Leu33Pro that were detected in our genome scan were present predominantly in male subjects, 18 we next performed these analyses in the male Hutterites only (Figure 1b ). Every ITGB3 SNP shows strong association (P 2-tail o0.01) with serotonin levels in this multipoint test, and for each SNP in ITGB3 except one (SNP 19), the common allele was associated with decreased levels. Because many SNPs within ITGB3, but none in the flanking genes, were associated with serotonin, the region of association was narrowed to ITGB3. However, we could not refine our association signal to a smaller subset of SNPs in the Hutterites. We next examined whole-blood serotonin levels in an outbred sample of healthy Chicago Caucasian and AfricanAmerican controls who were previously genotyped for SNPs in ITGB3. 21 The Chicago control sample was, by chance, largely female (67 of 92 individuals), although the ITGB3 association in the Hutterites was more significant in male subjects. In the Chicago control sample, four SNPs near the 5 0 end of ITGB3 were associated with serotonin levels with P 1Àtail o0.05, and the strongest associations were detected with SNPs 1 and 4 (P 1Àtail ¼ 0.010 and 0.011, respectively; Figure 1b) . Nonetheless, common alleles of ITGB3 were associated with relatively lower whole-blood serotonin levels, as in the Hutterites. We verified that the female subjects contributed to this signal, as removing them left no significant association (data not shown). These P-values are only nominally significant, considering that we tested 19 SNPs in ITGB3, some of which were in strong LD (making Bonferroni correction conservative) (Figure 2 ).
An autism sample served as the second replication sample for our studies of ITGB3 and whole-blood serotonin levels. This sample reflects the large male bias in autism (39 of 50 subjects were male). Five SNPs were selected for genotyping in this sample based on results in the Hutterites and Chicago controls: SNPs 1, 8, 11, 14, and 18. In this sample, the common allele at the silent SNP in exon 9 (SNP 11) was associated with lower serotonin levels (P 1Àtail ¼ 0.015; Figure 1b) . Interestingly, this association in a largely male sample of individuals with autism was not driven by the hyperserotonemic individuals in the sample (data not shown), rather it was consistent with the multipoint results in male Hutterites (Figure 1) , where the common allele at SNP 11 showed the most significant association with lower whole-blood serotonin levels, and is the third independent sample in which noncoding variation in ITGB3 is associated with serotonin. (b) Association of ITGB3 alleles with serotonin levels. Arrows below the gene structure schematic indicate SNPs that were genotyped in the complete Hutterite and Chicago control samples, and the shading of boxes below these arrows reflects P-values corresponding to association at each SNP. The outbred control sample was predominantly female (67 of 92), thus power-limited sex-specific analyses are not shown. Based on these results, four SNPs (1, 4, 8, and 11) were genotyped in the predominantly male (39 of 50) Chicago autism sample. The SNP associated in this sample (Po0.05) is designated with a star below the P-value schematic. Linear regression using an additive model was used in both outbred samples.
Although different polymorphisms were most associated in the three samples, estimates for the effect size of ITGB3 variants on whole-blood serotonin were remarkably similar across populations and SNPs. For each population, we estimated effect size using the most strongly associated SNP by single-point analysis: SNP 14 in the Hutterites (data not shown; method according to Abney et al 34 ) , SNP 1 in the Chicago sample, and SNP 11 in the autism sample. Although using the most significantly associated SNP may result in a slight upwards bias in effect size, the estimates still provide valuable information. In the male Hutterites, genotype at SNP 14 explained 6.8% of the variance in serotonin levels; heterozygotes at this SNP had a 12.7% increase in serotonin levels compared to homozygotes for the common allele. Effect size in homozygotes for the rare allele could not be accurately estimated, because there were too few individuals with this genotype (N ¼ 4). Among outbred controls, genotype at SNP 1 explained 7.7% of the variance in serotonin levels; heterozygotes had a 17.4% increase in serotonin level in our additive model compared with homozygotes for the common allele. In the autism sample, genotype at SNP 11 explained 9.7% of the variance in serotonin levels; heterozygotes had a 17.0% increase in serotonin level compared with homozygotes for the common allele. These three SNPs are not in LD in the Hutterites or Chicago controls (r 2 o0.2).
A coding SNP in ITGB3 is associated with autism, with different effects in male and female subjects The ultimate aim of these studies was to determine whether alleles at ITGB3 that were associated with serotonin levels were also associated with autism. We first performed a TDT to test for joint linkage and association in 87 Chicago autism trios, 50 of whom were included in the serotonin studies described above. The common allele (Leu) at ITGB3 SNP 8 (frequency 0.88) was modestly overtransmitted to autism probands at a 3:2 ratio, but was not statistically significant in this small sample (T ¼ 21 vs NT ¼ 14; P ¼ 0.24; associated with serotonin level in autism probands. A sexspecific analysis of this sample was not performed, as there were too few informative transmissions to female subjects (69 affected male and 18 affected female subjects).
We next genotyped a larger sample from Vanderbilt (643 largely multiplex families) for eight SNPs across ITGB3. In these families, the Leu allele at SNP 8 (frequency 0.87) was significantly overtransmitted to affected individuals (FBAT, T EXPECTED ¼ 523 vs T OBSERVED ¼ 555; P ¼ 0.0017; Table 1 ). When we combined the two autism samples, the association became more significant (FBAT, P ¼ 0.00082). These results remained very significant when the FBAT analysis considered the presence of linkage in the region (P ¼ 0.00076; Table 2) .
Surprisingly, when we examined transmission to affected males vs females, the association between ITGB3 Leu33 and autism was stronger in female subjects (T EXPECTED-MALE ¼ 410 vs T OBSERVED-MALE ¼ 424; P ¼ 0.13; T EXPECTED-FEMALE ¼ 125 vs T OBSERVED-FEMALE ¼ 143; P ¼ 0.00024), under an additive model (Table 2a) . Further characterization of the association using FBAT to test transmissions under a dominant model suggests that this variant has reciprocal dominant effects in male and female subjects (Table 2b) . Analysis by FBAT in male subjects shows a dominant risk effect of the Leu33 allele (T EXPECTED-MALE ¼ 27 vs T OBSERVED-MALE ¼ 34; P MALE ¼ 0.014; Table 2b ). In females, however, the Pro33 allele has a dominant protective effect (T EXPECTED-FEMALE ¼ 45 vs T OBSERVED-FEMALE ¼ 27; P FEMALE ¼ 7.9 Â 10 À5 ). To further evaluate these sex differences, we employed MODEL, which fits genetic models based on TDT information. 38 This analysis indicates that both male and female subjects show a significant effect at this locus (P MALE ¼ 0.0066, P FEMALE o0.0001), but that the effects in these two samples are significantly different, confirming a gene-by-sex interaction (P ¼ 0.0018). In agreement with FBAT analyses, MODEL shows that female data best fit a recessive risk effect, whereas male data best fit a dominant risk effect of the Leu33 allele (Table 3) .
Discussion
ITGB3, a gene identified as a male QTL for whole-blood serotonin levels in the Hutterite founder population, is also a QTL for serotonin in outbred populations. In three samples, serotonin levels were associated with noncoding SNPs that account for 7 -10% of the population variance in their respective samples. Extrapolating from studies of quantitative traits in model organisms in which most QTLs have effect sizes less than 5%, 39 we predict that the ITGB3 effect sizes observed in our study contribute substantively to interindividual variation in serotonin level in multiple populations. Surprisingly, noncoding polymorphisms were more strongly associated with serotonin level than Leu33Pro in the Hutterites, Chicago controls, and the Chicago autism sample. A possible explanation is that one or more untyped variants are responsible for serotonin level and/or autism association, and the current association signals are the results of LD with markers we have not genotyped. However, we consider this unlikely because the SNPs associated in each sample were not in strong LD with each other. Alternatively, it is possible that more than one polymorphism at the ITGB3 locus has functional consequences. For example, noncoding variants could affect transcription or RNA processing, and this gene could show pleiotropy, such that effects on autism and serotonin levels are independent and influenced by different variation, perhaps intersecting in a common pathway. This would be consistent with our data, and with the various functional roles and locations of integrins, including effects on transcription and cell -cell signaling.
We were very surprised to find that the common Leu33 allele, which is associated with lower serotonin levels in the Hutterites, was associated with autism. Male-biased autism is known for its correlation to relatively higher serotonin levels in B30% of patients. How can we resolve these findings? First, the association between Leu33 and autism is not likely to explain the hyperserotonemia in autism. It is notable, however, that more patients are responsive to SSRI medications (B50%) than are hyperserotonemic. 40 Therefore, we cannot exclude the possibility that even within the normal range of platelet serotonin levels, perturbations of the broader serotonin system (eg centrally) due to variation at ITGB3 might contribute to autism susceptibility. The functions of integrin b3 have been most extensively studied in platelets; however, two previous findings should be noted. First, it has been hypothesized that high peripheral serotonin levels might influence central serotonin by feedback mechanisms before formation of the blood -brain barrier. 41 Second, integrins, including b3, have been shown to be critical to synapse maturation in the hippocampus, 42 suggesting not only expression but also vital function in the developing brain. Both male and female subjects show evidence for association of the Leu33 allele to autism; however, our data suggest that the allele has different effects on autism risk in male and female subjects, with the best-fitting models suggesting a dominant effect in male subjects and recessive effect in female subjects. We cannot exclude the possibility that the apparent difference in autism risk for male and female subjects is a chance finding. There could also be genetic modifiers or interactions that differ by sex, and failing to model for them could cause the main effects at ITGB3 to look different by sex. Many important questions remain, including the effect of Leu33Pro and other ITGB3 variation on serotonin levels by sex in large samples of control and autism subjects. In addition, the association of Leu33 with decreased serotonin level in the Hutterites (when hyperserotonemia is associated with autism) highlights the need for further investigation of our findings. An association with autism is particularly interesting, as chromosome 17q23 was not identified as a linkage region in autism in the 12 genome screens performed before its identification as a QTL for serotonin levels. 35 -45 However, two recent genome-wide studies report suggestive to significant evidence for linkage to autism in this region, 43, 44 and a meta-analysis indicates 17q22 -q23 as significant at Po0.05. 45 Our findings support the idea that teasing apart a quantitative trait (whole-blood serotonin level), likely to be related to the etiology of a complex disease, can be useful in identifying candidate loci for subsequent analysis.
